for the six months ended
June 30, |
||||
In 000€ | 2021 |
2020 (*) |
||
Operating activities | ||||
Net (loss) profit for the period | (224) |
(4,869) |
||
Non-cash and operational adjustments | ||||
Depreciation of property plant & equipment | 7,591 |
7,493 |
||
Amortization of intangible assets | 2,335 |
2,284 |
||
Share-based payment expense | (774) |
- |
||
Loss (gain) on disposal of property, plant & equipment | 48 |
46 |
||
Movement in provisions | 5 |
4 |
||
Movement reserve for bad debt | 204 |
181 |
||
Financial income | (2,556) |
(845) |
||
Financial expense | 5,515 |
2,453 |
||
Impact of foreign currencies | 87 |
36 |
||
Share in loss (gain) of a joint venture (equity method) | - |
39 |
||
(Deferred) income taxes | (25) |
266 |
||
Other non-current liabilities | - |
|||
Working capital adjustments & income tax paid | ||||
Decrease (increase) in trade receivables and other receivables | (1,528) |
8,962 |
||
Decrease (increase) in inventories | (1,188) |
1,220 |
||
Decrease (increase) in trade payables and other payables | 3,439 |
(1,843) |
||
Interest received | 313 |
- |
||
Income tax paid | (140) |
(1,102) |
||
Net cash flow from operating activities | 13,102 |
14,326 |
for the six months ended
June 30, |
||||
In 000€ | 2021 |
2020 (*) |
||
Investing activities | ||||
Purchase of property, plant & equipment | (2,453) |
(5,756) |
||
Purchase of intangible assets | (1,562) |
(687) |
||
Proceeds from the sale of property, plant & equipment & intangible assets (net) | 222 |
72 |
||
Convertible loan to third party | (4,370) |
(300) |
||
Investment in joint-ventures | - |
- |
||
Net cash flow used in investing activities | (8,163) |
(6,671) |
||
Financing activities | ||||
Proceeds from loans & borrowings | - |
15 |
||
Repayment of loans & borrowings | (7,219) |
(5,813) |
||
Repayment of finance leases | (1,909) |
(1,823) |
||
Capital increase | 74,346 |
140 |
||
Interest paid | (1,064) |
(1,178) |
||
Other financial income (expense) | 1,580 |
(617) |
||
Net cash flow from (used in) financing activities | 65,734 |
(9,276) |
||
Net increase of cash & cash equivalents | 70,673 |
(1,621) |
||
Cash & Cash equivalents at the beginning of the year | 111,538 |
128,897 |
||
Exchange rate differences on cash & cash equivalents | 605 |
(1,822) |
||
Cash & cash equivalents at end of the year | 182,816 |
125,454 |
(*) |
The year 2020 has been restated to reflect the final accounting of the business combination with Engimplan. |
|
Impact on the year to date operating result of the (83) kEUR |